PMID- 38162612
OWN - NLM
STAT- MEDLINE
DCOM- 20240103
LR  - 20240424
IS  - 2296-2565 (Electronic)
IS  - 2296-2565 (Linking)
VI  - 11
DP  - 2023
TI  - Factors associated with nonattendance at annual diabetes check-up in Ningbo, 
      China: a case-control study.
PG  - 1247406
LID - 10.3389/fpubh.2023.1247406 [doi]
LID - 1247406
AB  - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a grave issue in China. The annual 
      check-up is recommended in clinical guidelines on T2DM. It plays an important 
      role in monitoring and managing the condition and detecting and managing any 
      comorbidities and T2DM-related complications. However, people with T2DM may miss 
      the annual check-up, and the benefits of this check-up are lost. Therefore, this 
      study aimed to determine the factors associated with nonattendance at the annual 
      T2DM check-up in Ningbo, China. METHODS: A case-control study was conducted using 
      the Ningbo National Metabolic Management Center dataset. Cases were people with 
      T2DM who were alive but did not attend the first annual check-up, scheduled 
      between 1 March 2019 and 28 February 2022 (n = 1,549). Controls were people with 
      T2DM who were alive and attended the first annual check-up during the same period 
      (n = 1,354). The characteristics of cases and controls were compared using 
      logistic regressions. RESULTS: The odds of being a female [odds ratio (OR) 1.26, 
      95% confidence interval (CI) 1.06-1.50], alcohol drinker (1.26, 1.06-1.49), and 
      with glycated hemoglobin A1c (HbA1c) >/=7% (1.67, 1.42-1.97) were higher among case 
      patients than controls. The odds of being a high school graduate (0.77, 
      0.66-0.89) and on standard treatments in addition to lifestyle modification (oral 
      hypoglycemic drug 0.63, 0.42-0.96; oral hypoglycemic drug and injection therapy 
      0.48, 0.32-0.73) were lower among case patients than controls. CONCLUSION: The 
      factors associated with nonattendance at the annual T2DM check-up in Ningbo, 
      China were female sex, not a high school graduate, alcohol drinker, HbA1c >/=7%, 
      and only on lifestyle modification. The study findings should be used for 
      improving attendance at the annual check-up among people with T2DM in Ningbo.
CI  - Copyright (c) 2023 Li, Chattopadhyay, Li, Yu, Xu, Chen, Li and Li.
FAU - Li, Ling
AU  - Li L
AD  - Health Science Center, Ningbo University, Ningbo, China.
AD  - Department of Endocrinology and Metabolism, The First Affiliated Hospital of 
      Ningbo University, Ningbo, China.
FAU - Chattopadhyay, Kaushik
AU  - Chattopadhyay K
AD  - Lifespan and Population Health, School of Medicine, University of Nottingham, 
      Nottingham, United Kingdom.
FAU - Li, Xueyu
AU  - Li X
AD  - Department of Endocrinology and Metabolism, The First Affiliated Hospital of 
      Ningbo University, Ningbo, China.
FAU - Yu, Jingjia
AU  - Yu J
AD  - Department of Endocrinology and Metabolism, The First Affiliated Hospital of 
      Ningbo University, Ningbo, China.
FAU - Xu, Miao
AU  - Xu M
AD  - Department of Endocrinology and Metabolism, The First Affiliated Hospital of 
      Ningbo University, Ningbo, China.
FAU - Chen, Xueqin
AU  - Chen X
AD  - Department of Traditional Chinese Medicine, The First Affiliated Hospital of 
      Ningbo University, Ningbo, China.
FAU - Li, Li
AU  - Li L
AD  - Department of Endocrinology and Metabolism, The First Affiliated Hospital of 
      Ningbo University, Ningbo, China.
FAU - Li, Jialin
AU  - Li J
AD  - Department of Endocrinology and Metabolism, The First Affiliated Hospital of 
      Ningbo University, Ningbo, China.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20231214
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
RN  - 0 (Glycated Hemoglobin)
RN  - 0 (Blood Glucose)
RN  - 0 (Hypoglycemic Agents)
SB  - IM
MH  - Humans
MH  - Female
MH  - Male
MH  - *Diabetes Mellitus, Type 2/therapy/drug therapy
MH  - Glycated Hemoglobin
MH  - Case-Control Studies
MH  - Blood Glucose/metabolism
MH  - China/epidemiology
MH  - Hypoglycemic Agents/therapeutic use
PMC - PMC10755863
OTO - NOTNLM
OT  - China
OT  - annual checkup
OT  - attendance
OT  - chronic disease management
OT  - type 2 diabetes mellitus
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2024/01/02 11:45
MHDA- 2024/01/03 09:42
PMCR- 2023/12/14
CRDT- 2024/01/01 04:25
PHST- 2023/06/26 00:00 [received]
PHST- 2023/11/21 00:00 [accepted]
PHST- 2024/01/03 09:42 [medline]
PHST- 2024/01/02 11:45 [pubmed]
PHST- 2024/01/01 04:25 [entrez]
PHST- 2023/12/14 00:00 [pmc-release]
AID - 10.3389/fpubh.2023.1247406 [doi]
PST - epublish
SO  - Front Public Health. 2023 Dec 14;11:1247406. doi: 10.3389/fpubh.2023.1247406. 
      eCollection 2023.